Preferential induction of RET/PTC1 rearrangement by X-ray irradiation
نویسندگان
چکیده
منابع مشابه
Induction of radioresistant nasopharyngeal carcinoma cell line CNE-2R by repeated high-dose X-ray irradiation
Background: All To enhance the curative effect of radiotherapy, we established a radio-resistant cell line, CNE-2R from CNE-2, a radio-sensitive type of CNE, through repeated irradiation. The developed cell line provides a basis for further studies on the radio-resistance of CNE and the molecular mechanism of radiotherapy sensitization drugs. Materials and Methods: The CNE-2 cell line was selec...
متن کاملFabrication of single crystal CuGaS2 nanorods by X-ray irradiation.
CuGaS(2) nanorods were synthesized by irradiating the precursor solution with intense X-rays. The products are single crystal nanorods with preferential [220] growth and a uniform size distribution. We also report on the photoresponse of drop-cast films of these nanorods.
متن کاملMutation of Phytomonas Stewartii by X-Ray Irradiation.
ARIATION in cultural characteristics, viability, and motility of bacV teria has been recognized almost from the beginning of their study in pure culture. Because of the influence of the Koch school, which emphasized cultural purity, early bacteriologists were prone to attribute changes in cultures to contamination. Thus, many of the earlier observations of bacterial variation probably were disc...
متن کاملIndirect induction of vascular damage by x-irradiation.
T HE increased vascular permeability and hemorrhagic defects which have been observed following total body irradiation have been attributed to many causes. Cronkite et al. 1>2 correlated these changes with the well demonstrated thromboeytopenia 3 which occurs a few clays after exposure to whole-body ionizing radiation. However, there are a considerable number of reports which suggest that the e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncogene
سال: 2000
ISSN: 0950-9232,1476-5594
DOI: 10.1038/sj.onc.1203343